- Time to Chemotherapy for Patients With Estrogen Receptor-Positive Breast Cancer and Cyclin-Dependent Kinase 4 and 6 Inhibitor Use
-
Endo Y, Yoshimura A, Sawaki M, Hattori M, Kotani H, Kataoka A, Horisawa N, Ozaki Y, Nozawa K, Takatsuka D, Isogai A, Iwata H
- KMID: 2532786
- J Breast Cancer.
- 2022 Aug;25(4):296-306.
- doi: 10.4048/jbc.2022.25.e34
Purpose: Safely postponing the use of chemotherapy is important for quality of life maintenance in patients with hormone receptor-positive advanced breast cancer. In previous studies, a combination of cyclin-dependent kinase... -
- CITED
-
- Close
- SHARE
-
- Close
